Eric Warren - 04 Mar 2026 Form 3 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Chief Commercial Officer
Signature
/s/ Eric Warren
Issuer symbol
MLYS
Transactions as of
04 Mar 2026
Net transactions value
$0
Form type
3
Filing time
04 Mar 2026, 19:25:12 UTC
Previous filing
21 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Warren Eric Chief Commercial Officer 150 N. RADNOR CHESTER RD., RADNOR /s/ Eric Warren 04 Mar 2026 0001916048

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MLYS Common Stock 38,400 04 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MLYS Stock Option 04 Mar 2026 Common Stock 357,000 $13.24 Direct F2
holding MLYS Stock Option 04 Mar 2026 Common Stock 51,300 $28.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units (RSUs) that were granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of February 19, 2026, the date of grant.
F2 The stock option vests as to 25% of the underlying shares on the first anniversary of April 21, 2025, the date of grant, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
F3 The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following February 19, 2026, the date of grant.

Remarks:

EXHIBIT LIST: Exhibit-24 Eric Warren POA